Stay updated with breaking news from Informa Pharma Intelligence. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Pharmaprojects' 2022 Report Highlights Breakthrough Trends in Pharmaceutical R&DNEW YORK, March 24, 2022, the global business intelligence provider for the biopharma industry, today announced the launch
Investegate announcements from Informa Business Intelligence, Informa Pharma Intelligence Launches 30th Edition Pharma R&D Annual Review
The potential demand for biosimilars undoubtedly generates an enormous opportunity for biopharmaceutical companies. However, biosimilar development and commercialiszation is an inimitably complex endeavour requiring a precise, stepwise strategy to ensure timely regulatory approval and optimum market access. Even companies that are aiming to protect the market share of a branded biologic product are compelled to adapt to the increased competition from biosimilars. Given these dynamics, the uniqueness of biosimilars necessitates that an integrated, strategic development and commercial plan must ...
A bold vision for the future is redefining corporate strategy for pharmaceutical and biotech companies, with new opportunities arising from…
UK Adults Call on Pharma Companies to Keep Improving COVID-19 Treatments Without Sidelining Other Conditions New research captures Brits’ attitude to COVID-19 treatment options London, 06.01.2021 – Pharma...